143 related articles for article (PubMed ID: 2451760)
1. Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney.
Wiegers K; Uhlig H; Dernick R
J Virol; 1988 May; 62(5):1845-8. PubMed ID: 2451760
[TBL] [Abstract][Full Text] [Related]
2. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
3. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
Wiegers K; Uhlig H; Dernick R
Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
[TBL] [Abstract][Full Text] [Related]
4. Revertants of poliovirus escape mutants: new insights into antigenic structures.
Ketterlinus R; Wiegers K; Dernick R
Virology; 1993 Feb; 192(2):525-33. PubMed ID: 8380664
[TBL] [Abstract][Full Text] [Related]
5. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
[TBL] [Abstract][Full Text] [Related]
7. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
[TBL] [Abstract][Full Text] [Related]
8. Location and primary structure of a major antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
[TBL] [Abstract][Full Text] [Related]
9. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
Wiegers KJ; Wetz K; Dernick R
J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
[TBL] [Abstract][Full Text] [Related]
11. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
12. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
13. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.
Zhou YJ; Burns JW; Morita Y; Tanaka T; Estes MK
J Virol; 1994 Jun; 68(6):3955-64. PubMed ID: 7514681
[TBL] [Abstract][Full Text] [Related]
14. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
Fallahi F; Wandeler AI; Nadin-Davis SA
Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
[TBL] [Abstract][Full Text] [Related]
15. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
Taniguchi K; Urasawa S
Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
[TBL] [Abstract][Full Text] [Related]
16. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
Evans DM; Minor PD; Schild GS; Almond JW
Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
[TBL] [Abstract][Full Text] [Related]
17. Antigenic variation and resistance to neutralization in poliovirus type 1.
Diamond DC; Jameson BA; Bonin J; Kohara M; Abe S; Itoh H; Komatsu T; Arita M; Kuge S; Nomoto A
Science; 1985 Sep; 229(4718):1090-3. PubMed ID: 2412292
[TBL] [Abstract][Full Text] [Related]
18. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
Martin A; Wychowski C; Benichou D; Crainic R; Girard M
Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
[TBL] [Abstract][Full Text] [Related]
19. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
20. Natural variation of poliovirus neutralization epitopes.
Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
